StockWatch
·

BERYL DRUGS LTD. Q3 FY25 Results

BERLDRGQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue5.315.4%
Total Income5.404.3%
Expenditure5.245.3%
PBT0.1649.1%
Net Profit0.05642.9%
OPM-6.88%0.09pp
NPM0.96%0.84pp
EPS0.10900.0%
View full financials

Informational and educational content only. Not investment advice.